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Abstract: 
Purpose: This was a test to detect whether a 4-week cognitive behavioral nursing program was 
effective in increasing adjustment to fibromyalgia (FM) and if the treatment effect would last 
over time. 
Design: This was a control and treatment group experimental longitudinal study with outcome 
measures obtained at pretest and every 3 months for 1 year. 
Sample: A sample of 71 subjects continued their participation throughout the first year of the 
study. 
Findings: Treatment subjects had improved posttreatment adjustment and symptom severity 
compared to control subjects. When subjects with high pretest psychosocial distress (n = 5) were 
removed from the analysis, these findings were statistically significant. 
Implications for Nursing Practice: The article can provide direction for developing new 
comprehensive nursing intervention for patients seen with orthopaedic problems. The 
intervention schedule may help nurses expand their use of interventions for FM patients. 
Orthopaedic nurses are especially suited for this challenge. 
 
Article: 
Fibromyalgia (FM) is a chronic illness characterized by widespread pain with trigger point 
tenderness, fatigue, and nonrestorative sleep disturbances that are very resistant to treatment 
(Kaplan et al., 1993). It is estimated that 7–10 million people in the U.S. are affected (Colorado 
HealthNet, 1996). 
 
Individuals with FM are predominately Caucasian (Wolfe et al.,1996), female (73–88%) 
(Boissevain & McCain, 1991), and middle aged (age x = 49.2) (White et al., 1999). No curative 
treatment is currently known or available, and yet little is being done to help patients make 
lifestyle adjustments to manage the illness. 
 
There are a variety of initiating factors for FM such as psychologic distress, sleep disorders 
(sleep apnea, limb movement disorder), inflammatory bowel syndrome, trauma, and familial 
tendency. In 51% of their FM respondents (Anderberg et al., 2000), stress from negative life 
events such as childhood and spousal conflicts as well as economic problems were cited as 
precipitating causes of the illness and exacerbations. Waylonis and Heck (1992) found some 
indication that FM may have a genetic basis. They reported that 25% of their FM patients had a 
parent with FM. 
 
Associated problems seen in individuals with FM include depression, spastic colon, mitral valve 
prolapse, bursitis, joint pain, constipation, diarrhea, temporal mandibular joint (TMJ) syndrome, 
and thyroid problems. Additional symptoms include sensory symptoms such as burning and 
numbness, swollen glands, tinnitus, chronic cough, coccygeal and pelvic pain, tachycardia, and 
weakness (Waylonis & Heck, 1992). Spasms of the blood vessels in the extremities, irritable 
bladder and bowel, tension headaches, and sexual problems are also frequently seen with FM 
(Ng, 1992). 
 
Of the subjects they studied (Waylonis & Heck, 1992), 70% reported that their symptoms were 
aggravated by increased noise, bright lights, stress, and changes in weather conditions, especially 
cold temperatures. Symptoms of FM are persistent with 85% of patients indicating significant 
symptoms and clinical evidence of FM 10 years after the trauma that triggered the FM (Waylonis 
& Perkins, 1994). 
 
In a 5-year follow-up study, Henriksson (1994) reported that in 50% of the patients, pain, 
fatigue, and sleep problems increased; less than 20% of the subjects improved; and 30–40% of 
the subjects reported no change. 
 
A significant problem leading to lost relationships, social isolation, and unemployment is 
cognitive dysfunction. Slotkoff and Claw (1996) recommend that FM patients should have 
optimal treatment for FM that focuses on improving FM and the use of compensation techniques 
to assist memory before cognitive testing. 
 
Neuropsychologic testing reveals cognitive problems with work usage, dyscalculia, 
concentration, comprehension, sequencing, decision making, visual spatial, fine and gross motor 
ability, and memory storage and retrieval. 
 
Cote & Moldofsky (1997) noted that FM patients had slower speed of performance than normal 
and performed more poorly on grammatical reasoning, serial addition/subtraction, and simulated 
multitask office procedures. Although FM patients performed more poorly than control subjects 
on tests of immediate and delayed recall and sustained auditory concentration, perceived 
memory deficits were disproportionately greater than their objective deficits (Grace et al., 1999). 
 
The reviewed studies indicate that FM often becomes a nonremitting syndrome with a variety of 
physical, social, and psychologic consequences that impair the patients' ability to manage 
everyday life activities. Due to the chronic nature of FM, nursing interventions are needed to 
help these individuals adjust to their disease. 
 
 
Treatment Programs for Fibromyalgia 
A number of treatment programs for FM patients have been reported in the literature. These 
programs can be categorized into four areas: exercise only, education only, behavioral and/or 
educational programs, and comprehensive treatment programs. 
 
Exercise Programs 
 
Studies of the effect of exercise in FM patients have focused largely on the premise that regular 
exercise may benefit the patient by decreasing fatigue and pain, and improving sleep. Mengshoel 
et al. (1992) conducted a 20-week program consisting of 60-minute exercise twice a week in 
which subjects failed to demonstrate changes in general pain, pain coping, or fatigue. However, 
the study emphasized that FM subjects can undergo low-intensity exercise program without 
experiencing exacerbation of their pain and fatigue. 
 
Likewise, Martin et al. (1996) demonstrated that exercise is beneficial for the management of 
FM in the short-term and that there were no adverse effects from a program including aerobic 
exercise, flexibility, and strength training. Although patients reported a perceived benefit with a 
6-month fitness program, it failed to produce improvement in physical fitness (Verstappen et al., 
1997). 
 
A 12-week exercise program for FM patients conducted by Norregard et al. (1997) had a high 
number of patients who withdrew from the program, and the program failed to produce 
improvements in pain, fatigue, general condition, sleep, depression, functional status, muscle 
strength, or aerobic capacity in any of the treatment groups. Ramsay et al. (2000) conducted a 
12-week aerobic exercise program that failed to improve pain control in FM participants, and 
there was no benefit to having a supervised exercise program over an unsupervised home 
exercise program. 
 
Two research teams tried combining exercise with biofeedback or psychologic support. 
Buckelew et al. (1998) combined biofeedback with exercise programs for FM patients but saw 
no improvement in tender point scores. However, the exercise/biofeedback participants did not 
show the deterioration demonstrated in the attention group. 
 
Keel et al. (1998) tested a combination of physiotherapy with psychologic support that produced 
an improvement (3 of 6 parameters) in only 18.5% of the treatment group. These exercise studies 
together provide little support for the benefit of a structured exercise program with or without 
biofeedback or psychologic help in improving FM symptoms. 
 
Behavioral and/or Educational Treatment Programs 
Several studies have reported on the benefits of behavior and/or educational programs. 
Following a 6-week program of exercise and education, some patients reported improvements in 
well-being, walking distance, self-efficacy, knowledge, and fatigue levels at 3 months, but the 
gains in fatigue and knowledge were lost at 6 months (Gowans et al., 1999). 
 
Participants in an 8-week course of educational/behavioral component, formal 
relaxation/meditation training, and Qi Gong (Chinese movement therapy) showed improved 
Fibromyalgia Impact Questionnaire scores, decreased tender points, and increased pain threshold 
(Creamer et al., 2000). 
 
Nicassio et al. (1997) compared behavioral and educational interventions at 6-month follow-up 
for the treatment of FM. Although they noted that subjects improved in levels of reported pain 
and levels of helplessness, there was no difference in the success rates due to type of program. 
Likewise, Vlaeyen et al. (1996) reported no advantage in cognitive/ education over the 
education/discussion group at 12-month follow-up. Goosen et al. (1996) examined FM patients 
at a 3-year follow-up and concluded that there was was no economic justification for the 
cognitive/education interventions given the higher cost for this type of program as compared to 
education. 
 
The Arthritis Foundation offers a 6-week educational program aimed at helping individuals 
adjust to FM. This course has some limitations in that it does not collect outcome data to 
measure the effectiveness of these programs, it lacks behavioral modification component, and 
classes are often led by lay people (Personal Communication). 
 
The literature does not support the use of educational programs alone in improving symptom 
management nor adjustment to FM. For these educational programs to be effective, they must be 
combined with a more comprehensive approach to the management of FM. 
 
Comprehensive Treatment Programs 
Maurizio and Rogers (1997) recommend that while patient education is crucial for the 
management of FM, the clinician and patient need to identify a more comprehensive 
combination of treatment options and medications that are most helpful for each patient. 
Comprehensive treatment programs include medications, exercise, education, psychologic 
support, and behavior modification. Nielson et al. (1992) reported on a 3-week inpatient 
cognitive-behavioral treatment program with subjects (n = 25) noting less pain severity, 
emotional distress, anxiety, and depression at discharge. 
 
In another study by Turk et al. (1998a), 67 FM patients participated in a 4-week program of 
medical, physical, psychologic, and occupational therapies at the University of Washington in 
Seattle. They reported significant improvements in sense of control, distress, life interference, 
pain, physical impairment, fatigue, and anxiety at immediate posttreatment measures. At 6 
months, patients maintained improvement in pain, life interference, sense of control, distress, and 
depression. 
 
Bennett (1996) elaborated on the success of the 6-month multidisciplinary University of Oregon 
Health Science Center (OHSC) program (N = 104) with patients demonstrating improved 
Fibromyalgia Impact Questionnaire scores, improved quality of life, and decreased fatigue on 
24-month follow-up data analysis. 
 
The 6-month program includes monthly lectures and monthly support group meetings with 
individualized exercise, and physical and psychologic interventions as indicated. However, the 
length of the program, location, and use of a multidisciplinary team (two psychologists, an 
exercise physiologist, two rheumatologists, and a headache specialist) contribute to the expense 
of the program. Few patients with FM can afford to relocate to the west coast for 6 months to 
participate in the program, nor can they afford the cost of such a comprehensive program. 
 
Not all groups of FM patients respond to these treatment programs. Turk et al. (1998b) 
elaborated on differential responses by psychosocial subgroups of FM patients: dysfunctional 
(poor coping and high pain), interpersonally distressed, and adaptive copers. Interpersonally 
distressed groups responded poorly to treatment. Adaptive copers reported improvements in 
pain. The dysfunctional group reported significant improvement in pain, distress, perceived 
disability, and pain interference in their life. The researchers concluded that customizing 
treatment based on psychosocial profile would lead to enhanced treatment efficacy. 
 
It is notable that the literature in these four areas is mixed but suggests that FM patients can 
engage in moderate aerobic exercise safely without exacerbation of their symptoms and that a 
comprehensive plan of management is necessary for this patient population so that they might 
better adjust physically, emotionally, and socially. 
 
While the exercise and/or education-only programs are cost effective, they are not effective in 
helping FM patients to manage their illness. The comprehensive programs at Seattle and Portland 
are more successful but expensive due to the use of multiple specialists. This problem is 
compounded by the fact that few FM patients have the resources nor the opportunity to relocate 
for extended periods of time to the west coast for treatment. 
 
Nursing Intervention: Fibromyalgia Rehabilitation Program (FM-REHAB) 
This article reports the results of a nursing intervention program that incorporates the successes 
of previous work in this area. Most important, the FM REHAB program is unique in that it 
focuses on the management of the primary symptoms (pain, fatigue, sleep, and cognitive 
dysfunction) and improvements in sense of control, distress, life interference, physical 
impairment, and adjustment to FM. The program shares all of the major components with the 
OHSC program. However, the FM-REHAB program is conducted by a nurse rather than the use 
of an expensive multidisciplinary team. 
 
The FM-REHAB program meets for 4 consecutive weeks (2 hours/ week on one night) with 
homework and practice sessions on other days throughout the program. These changes are 
designed to make the intervention more portable (can be offered at any site) and cost effective. 
 
Theoretical Framework 
The theoretical framework for this study is Bandura's (1989) social cognitive theory (SCT) with 
an emphasis on increasing self-efficacy (SE) for adjustment behaviors. Self-efficacy is Bandura's 
term for an individual's confidence in being able to perform a given behavior. As SE increases, 
the likelihood of the individual's successful performance of a specific behavior increases along 
with the amount of effort and persistence in performing that behavior in the face of obstacles 
(Bandura, 1982). 
 
For nurses working with clients who have chronic physical disabilities, the client's persistence is 
essential in learning behavioral changes necessary for better adjustment. In a randomized, 
controlled trial of a 6-week exercise and education for individuals with fibromyalgia, Gowans et 
al. (1999) reported improvements in well-being, walking distance, and self-efficacy. 
 
Neerinckx et al. (2000) reported that FM and chronic fatigue patients with symptoms for more 
than 1 year and who had previous contact with self-help groups had compromised feelings of 
self-efficacy in dealing with both chronic fatigue syndrome and FM. Just as self-efficacy and 
coping strategies affect physical, social, emotional, and role functioning in chronic RA patients 
(Strahl et al., 2000), this should also be true for FM patients. 
 
Recently, other researchers have linked increased SE expectations with the symptoms and 
behaviors contained in the FM-REHAB intervention including pain, cognitive dysfunction, 
fatigue, and exercise behavior. After 4 months in an arthritis self-management course, 
participants significantly increased arthritis SE scores and decreased pain (Barlow et al., 1999). 
Participants in Keefe et al.'s (1999) 12-month arthritis treatment program demonstrated higher 
SE, lower psychologic and physical disability, and pain behavior than the control group. Lackner 
and Carosella (1999) noted that SE was a better predictor of lifting tasks than either pain control 
or psychologic distress in patients with low back pain. 
 
Increases in patients' SE for controlling pain and decrease external attributions were found to be 
essential to successful pain management (Coughlin et al., 2000). 
 
Treatment programs structured around increasing SE have also led to improved memory. Shifren 
(1999) reported that intellectual functioning related to mental health through SE and pain. Older 
adults who reported performing poorly on cognitive tasks reported less SE, more pain, and 
poorer mental health than those who performed well on cognitive tasks. Lowered SE for memory 
performance was expressed through increased anxiety about memory function, decreased 
evaluations of memory capacity, and increased perceptions of memory decline (Hood & Bruck, 
1997). 
 
McDougall (1998) tested a 4-week nine-session group intervention based on Bandura's SCT. She 
indicated that increased SE for preventing decline in their memories led to greater use of internal 
strategy of elaboration, and external strategies of lists and notes. Likewise, a 2-week, 4-session 
SE group intervention with older adults significantly increased both memory self-efficacy and 
memory performance in the treatment group (Dellefield & McDougall, 1996). 
 
Self-efficacy expectations have long been linked as one of the strongest predictors of exercise 
behavior. Frost et al. (2000) reported improved depression, pain self-efficacy, and walking 
distance at 1 year after participating in a functional restoration program for patients with low 
back pain. Higher levels of SE correlated with longer distance in ambulation (Moon & Backer, 
2000). 
 
Resnick (2000) emphasized that self-efficacy and outcome expectations significantly influenced 
exercise behavior in older adults. The changes in exercise self-efficacy after treatment 
significantly related to improvements in fatigue reduction, VO2 max, anxiety, depression, and 
quality of life in a study of cardiac rehabilitation patients conducted by Jeng and Braun (1997). 
These studies provide support for the use of SCT in structuring treatment programs for patients 
with FM. 
 
FM-REHAB Program 
The FM-REHAB program uses the four basic forms of behavior acquisition as proposed by 
Bandura in his Social Cognitive Theory: role modeling, verbal persuasion, performance 
accomplishment, and vicarious experience. The program was designed as a group program so 
that subjects can use others in the group as positive role models. 
 
Discussions (verbal persuasion) are designed to expose the subjects to methods for modifying 
their response to FM. Homework assignments allow subjects to use these newly learned 
behaviors in their everyday life (performance accomplishment) with a discussion of their success 
in group sessions the following week. The success of the other group members (vicarious 
experience) encourages other subjects to try the new adjustment behaviors. 
 
Components of the FM-REHAB program were developed using a review of the literature, two 
panels of experts (nurses and patients), and the principal investigator's experience in dealing with 
chronic illness for 30 years. The nursing intervention was designed to teach individuals with FM 
about the disease, symptom management (pain, fatigue, sleep, and cognitive dysfunction) and 
self-care behaviors. 
 
Behavioral components include medication use, improved communication with their health care 
provider, stretching and exercise, energy conservation, diet and nutritional supplements, sleep 
hygiene, responding to others' reactions to their FM, and cognitive retraining. 
 
Additionally, stress reduction activities (progressive muscle relaxation and guided visual 
imagery) are included in the FM-REHAB program as the literature demonstrated that the use of a 
stress reduction program resulted in improved well-being, pain levels, sleep, and fatigue levels in 
51% of FM subjects (Kaplan et al., 1993). 
 
It is hypothesized that the increased use of self-care behaviors will improve symptom 
management leading to improved adjustment, improved well-being, and increased activities (see 
Figure 1). 
 
 
Figure 1 Proposed Model 
 
FM-REHAB Program Content 
Pain Control and Medication Management 
Pain control in FM is approached from both a behavioral and medication management 
perspective. The expected outcomes are for participants to (1) be aware of recommended 
medications and doses of drugs used to manage pain, (2) facilitate self-management, and (3) 
facilitate discussion of disease management with their health care provider. They are given 
medication sheets to take to their health care provider listing recommended medications and 
dosage ranges as recommended by the Colorado Health Network (2000). 
 
Subjects are taught that antidepressants (Elavil, Flexeril, Sinequin, Xanax, Tranzone, Klonopin 
or Pamelor) are prescribed to decrease pain and promote sleep. The efficacy of pain medications 
such as aspirin, Tylenol, and NSAIDs, especially for patients with arthritis, are discussed. It is 
suggested that stronger narcotic medications (Codeine, Vicodin, Darvon, and Ultram) should be 
reserved for severe “break-through” pain. Serotonin-boosting medications (Prozac, Paxil, Zolof, 
Serzone, and Efflexor) are suggested for decreasing cognitive dysfunction and fatigue. Flexeril 
and Norflex may be useful in decreasing muscle spasms. Medications for irritable bladder 
(Ditropan) or irritable bowel (Butibel and Librax) are also discussed. 
 
The use of uricosuric drugs (Robinul, Guaifenesin) are mentioned because many of the patients 
have misperceptions regarding the efficacy of these drugs that require considerable diet and 
health care product restrictions. Drug brand names are used because this is less confusing for the 
participants. 
 
Behaviorally, participants are taught nonpharmacologic pain management strategies and 
communication skills to advocate for themselves when dealing with their health care provider. 
Rest, massage, exercise, stretching, heat, and cold are all nonpharmacologic modalities for 
managing pain. They are also given a list of health care providers in their area who have been 
recommended by other participants. 
 
Fatigue 
Energy conservation and good nutrition are essential in dealing with fatigue associated with FM. 
Treatment subjects are taught to pace their activities daily and weekly, balance rest and activity, 
and to seek early treatment for medical problems using “body listening” (cue recognition) for 
early signs of trouble. They learn to budget their limited energy resources much as they do their 
checkbook. Subjects examine activities that could be eliminated, redesigned, or delegated to 
others. 
 
Diet and Use of Dietary Supplements 
Following instruction on the food pyramid, participants are encouraged to eat a well-balanced 
diet. Because many FM patients have multiple chemical sensitivities and allergies, subjects are 
taught how to identify and avoid food allergies as much as possible. For irritable bowel 
syndrome, increase roughage consumption is recommended. Supplements with research support 
(Werbach, 2000) for FM symptom management include Vitamin B complex (improved nerve 
cell and immune functioning, decrease fatigue and depression), Vitamin C (increase immune and 
microcirculation functioning), magnesium and malic acid (decrease muscle pain), and zinc 
(increased immune functioning, muscle strength, and endurance; decrease pain and fatigue). 
 
Titrated doses of these supplements follow Werbach's (2000) guidelines. Mountz et al. (1995) 
reported decreased regional cerebral blood flow in FM patients. Because Ginkgo helps to 
increase cerebral blood flow, it is recommended. They are also cautioned to avoid excessive use 
of untested supplements and to watch for overdosing on supplements. 
 
Sleep Promotion 
Sleep promotion is another key area that is covered. Cote and Moldofsky (1997) noted that FM 
patients spent more time in stage 1 sleep and reported more problems with sleepiness, fatigue, 
pain, and negative mood than controls. 
 
Subjects learn the need to engage in regularly scheduled, moderate exercise and stretching, 
practice environmental control and good sleep hygiene, and have regular sleep hours even on the 
weekend. They are also cautioned to watch the effect of naps on their sleep. Tricyclic 
antidepressants are recommended to promote sleep along with a skeletal muscle relaxant such as 
cyclobenzaprine HCL (Flexeril). The use of sleeping pills and hypnotics should be restricted to 
very short periods. 
 
Stress Management 
Anderberg et al. (2000) provides evidence for stress being a causative factor in the development 
and exacerbation of FM. Unusual life stress frequently occurs in the period preceding increased 
symptoms. Stress management techniques (guided visual imagery and progressive muscle 
relaxation) are an integral part of the FM-REHAB program. Psychosocial issues that cause stress 
are covered, including role changes, need for social support, decision-making, prioritizing 
activities, and handling the reactions of others/self to FM disabilities. Employment, social 
security, vocational rehabilitation, disability compensation, support groups, and helpful agencies 
are discussed. 
 
Cognitive Dysfunction 
This is an area that is not reported as part of the comprehensive programs in the literature. The 
FM-REHAB Program teaches methods for decreasing the impact of cognitive dysfunction on 
subjects' lives. The serotonin increasing drugs, such as fluoxetine (Prozac), are useful for 
increasing low serotonin levels seen in FM patients. 
 
Increased seratonin levels will decrease fatigue and increase alertness. Participants are taught 
that decisions should not be made when the patient is fatigued, and they should break tasks into 
the smallest components that can be achieved sequentially without distractions. Even though 
they think that they may remember an important piece of information or directions, participants 
are encouraged to write down this material. 
 
Subjects are also given suggestions for cueing their memory such as post-it-notes, rehearsal, and 
repetition. Cognitive games such as jigsaw and crossword puzzles are suggested as helpful 
activities for stimulating memory. Suggestions for transportation, reading, coping with the 
medical maze and lifestyle management are also covered. (See Table 1 for Program Schedule.) 
 
 
Table 1 Treatment Session Content and Homework 
 
Hypotheses 
Individuals participating in the FM-REHAB treatment group will have improved (1) symptom 
management (pain, fatigue, and sleep), (2) self-efficacy for adjustment behaviors, and (3) 
adjustment at posttest measures compared to the control group. These hypotheses were tested 
using a two-group (treatment and control) experimental longitudinal study design. 
 
Methods 
Procedures 
Following human subjects' approval, a convenience sample of 93 adults with FM were recruited 
to participate in this pilot study. Study subjects were recruited from a television news report and 
support groups. Interested individuals called in to the research office. Then all potential subjects 
were sent letters inviting them to participate in the research. Informed consent was obtained from 
subjects who agreed to participate in the pilot study. They were randomly assigned to either 
treatment or control (mailed questionnaires only) groups following receipt of the informed 
consent. 
 
The treatment sessions were offered in the form of small treatment groups (less than 8 subjects 
per group) lead by the primary investigator from 7:00 p.m. until 9:00 p.m. over 4 consecutive 
weeks. Table 1 details the treatment schedule. 
 
Both treatment and control subjects completed study instruments pretreatment and at four 
posttreatment intervals (3, 6, 9, and 12 months). All instrument packets were assigned subject 
numbers to assure subject confidentiality and appropriate tracking of data. The master sheet that 
matched subjects with numbers was kept in a locked office accessible only to the research team. 
 
Sample 
Ninety-three subjects were initially recruited. Due to the statistical analyses used (repeated 
measures ANOVA), only subjects providing return data at all five measurement periods 
throughout year 1 were included. The final sample size of 71 subjects represented a 37% attrition 
rate. The mean pretest scores on all primary variables did not significantly differ between the 38 
treatment subjects and the 33 control subjects. 
 
There was no difference in primary variables in those who dropped out of the study. Eight of the 
control subjects dropped out of the study after discovering that they were assigned to the control 
group. Another five in the treatment group dropped out because they no longer had symptoms of 
fibromyalgia. The others were lost due to relocation and our inability to track them. 
 
The sample was 88% female, which represents the preponderance of women who are affected by 
this disorder. Both groups had a mean age of 51 years (range 15 to 76), degree of disability mean 
of 5 (range 0–10), and mean number of years with FM was 8. 
 
Instruments 
The questionnaires consisted of four instruments used to measure adjustment, self-efficacy, 
symptom severity, and demographic or FM characteristics. 
 
Self-efficacy for Adjustment Behaviors Scale (SEAB) 
The Self-efficacy for Adjustment Behaviors Scale (SEAB) consists of 26 adjustment behaviors 
with a 5-point Likert-type response pattern. Content validity is evident in the way items were 
generated using a review of the literature, expert panels of both patients and nurses, and the 
expertise of the primary investigator who has multiple sclerosis. Items include adjustment 
behaviors such as good diet, exercise, communication, knowledge of illness, appropriate 
medication use, social support, etc. Each item ranged from 1 to 5 with 1 being “No confidence” 
and 5 being “Total confidence.” A typical item is: I can communicate effectively with my health 
care provider. 
 
A sample of 256 individuals with multiple sclerosis completed this format of the SEAB in the 
instrument development study (Wassem, 2000). The Cronbach alpha coefficient of internal 
consistency reliability for this sample was 0.91. The SEAB has been used with patients who have 
either multiple sclerosis, FM, chronic fatigue syndrome, cardiovascular disease, arthritis, or 
systemic sclerosis with Cronbach alpha levels ranging from 0.88 to 0.93. The Cronbach alpha 
statistic for internal consistency reliability for the SEAB with the present study was 0.93. 
 
Construct validity was tested by correlating SEAB scores with perceived self-report adjustment 
items that were significant at a moderate levels: social (r = .40), psychologic (r = .39), and 
physical adjustment (r = .43). 
 
Psychosocial Adjustment to Illness Scale (PAIS-SR). 
An adaptation of the PAIS-SR was used to measure adjustment. The Psychosocial Adjustment to 
Illness Self-Report Scale (PAIS-SR) has been shown to be a valid, reliable, and objective 
measure of adjustment to illness (Derogatis, 1986). 
 
The 45-item instrument consists of seven subscales: health care orientation, sexual relationship, 
extended family relationships, vocational environment, domestic environment, social 
environment, and psychologic distress. 
 
Due to consistent problems of low reliability levels and missing data that were apparent with two 
subscales (sexual relationships and extended family relationships), they were eliminated for this 
study. This dropped the number of items used to 34 items. 
 
Because of the small sample size for the current pilot study, the PAIS-SR was used as a total 
score. The Cronbach alpha statistic for internal consistency reliability for the total PAIS was 0.93 
for the current study. Adjustment was also measured using self-report adjustment items that are 
covered in the personal inventory description. This allows for multiple measures of this primary 
dependent variable. 
 
Modified Disability Status Scale (MDSS) 
A modified Disability Status Scale (DSS) was developed by the researcher as a measure of the 
respondent's level of disability. The Kurtzke (1970) Disability Status Scale that has been used as 
an objective and reproducible method of assessing the degree of disability in individuals with 
MS. 
 
Modification of the Kurtzke tool was made because only the second part of the instrument that 
ranks disability levels from 0 (no disability) to 9 (complete bed rest) was used. The first half of 
the instrument requires a physical exam that was not possible within budgetary constraints. 
 
The subjects were asked to circle the number that best represented their current level of 
functioning on this single-item measure. As this is a single-item measure of physical functioning, 
a measure of internal consistency reliability is not appropriate. 
 
Adjustment and Symptom Management Scores 
Adjustment scores were measured by circling the number 0 (no adjustment) to 10 (totally 
adjusted) for each adjustment item (psychologic, social, and physical). 
 
Total adjustment scores are the sum of the three adjustment items with a possible range of 0–30. 
 
Similarly, symptom management scores were obtained by circling the number that best indicates 
the difficulty they have with pain, fatigue, and sleep using a 10-point measurement from 0 (no 
difficulty) to 10 (maximum difficulty). The symptom severity score is the sum of these symptom 
scores with a possible range of 0–30. 
 
Personal Inventory 
A personal inventory was designed by the investigator to gather demographic data and 
information about the subject's illness. Items on the personal inventory were selected for 
relevance to the study, significance from the review of literature, and review by a panel of 
experts. Demographic variables in the personal inventory included age, gender, marital status, 
and length of disability. 
 
Data Analysis 
The data were entered into the computer upon receiving the completed mailed surveys. The 
researcher used the Statistical Package for Social Scientist (SPSS) software package for data 
analysis and hypothesis testing. All hypotheses were tested at the probability < .05 alpha level of 
significance. 
 
The analysis of the treatment/control group by time interaction was used to test for significant 
improvement in the treatment group over the control group. Hypotheses were tested using F 
statistics from the repeated measures analysis of variance (ANOVA) and analysis of Covariance 
(ANCOVA) procedure. 
 
Results 
Hypothesis 1 stated that the treatment group would have improved adjustment scores at posttest 
measures compared to the control group. The repeated measures ANOVA for Psychosocial 
adjustment to illness scale (PAIS) time effect was significant (F = 2.39, p = .03) and the repeated 
measures ANCOVA for treatment effect was not significant (F = .507, p = .36). 
This means that the PAIS adjustment scores improved for both groups, but the treatment group 
did not improve significantly more than the control group for the total sample. Hypothesis one 
was not supported by the total sample. 
 
We removed those subjects (n = 5) from the analysis who had a high level of pretest 
psychosocial distress (total adjustment < 9) following the findings on treatment subgroup 
patterns by Turk et al. (1998b). 
 
A subanalysis repeated measures ANCOVA that excluded subjects with high pretreatment 
psychosocial distress demonstrated that the treatment group scored significantly higher PAIS 
adjustment scores than the control group (F = 2.82, p = 0.02) which supports Hypothesis 1. Both 
groups showed some improvement, but the modest improvement in the control group decreased 
at 9 months, whereas the control treatment group continued their improvement (see Figure 2). 
 
Figure 2 PAIS Scores minus high pretest psychopathology group 
 
Using the self-report scores of perceived social adjustment, psychologic adjustment, and physical 
adjustment, both psychologic adjustment (p = .031) and physical adjustment (p = .0015) had 
significant improvement over time but social adjustment (p = .42) did not improve. 
 
Hypothesis 2 stated that control subjects will report higher self-efficacy scores posttest than 
control subjects. The SEAB scores for the treatment group were significantly higher than the 
control group at 3 and 6 months, fell off at 9 months, and increased at 12 months. The ANOVA 
for SEAB time effect was significant (F = 5.775, p = .0005) but the ANCOVA for the treatment 
effect was not significant (F = .591, p = .33). Therefore, Hypothesis 2 was not supported by the 
total study data nor the subsample analysis. 
 
Hypothesis 3 tested if the FM-REHAB treatment group had better symptom management at 
posttest measures compared to the control group. Total symptom disruption scores, which 
consisted of the sum on the three symptom scores (pain, fatigue, and sleep disturbance), were 
used to test Hypothesis 3. The repeated measures ANCOVA for treatment effect was not 
statistically significant for the total sample. 
 
Using the subanalysis described in Hypothesis 1, total symptom severity was statistically lower 
for the treatment group than the control group (F = 1.1, p = 0.05) providing support for 
Hypothesis 3 with this subanalysis. Most of this difference was due to improved sleep scores (F 
= 1.34, p = 0.031). Maximum treatment effects for pain and fatigue were seen at the 6-month 
data collection point with regression of symptom control at 9 months and a trend toward 
improvement at 12 months (see Figures 3 and 4). 
 
 
Figure 3 Symptom severity minus high pretest psychopathology group  
 
 
Figure 4 Sleep disturbance minus high pretest psychopathology group 
 
Discussion 
After excluding those with high pretest psychosocial distress, the treatment was effective in 
improving adjustment in study participants. It is interesting to note that treatment subjects 
increased their psychologic and physical adjustment more than the control group, but we did not 
see similar increases in social adjustment. 
 
Many FM patients become socially isolated following loss of jobs and alienation from family 
and friends. This finding of no improvement in social adjustment provides support for the 
importance of establishing and maintaining an adequate social support system. It is also 
consistent with Kenner's (1998) call for holistic treatment plans for FM that include emotional 
and physical support for both the patient and family. 
 
The treatment program was also successful in reducing symptom severity in study participants. 
Most of the improvement in symptom severity was due to improved sleep. This is consistent with 
the belief that sleep disturbance may be the etiology of the problem with FM. The slight increase 
in symptom distress at the 9-month data collection could be attributed to the busy holiday season 
with participants doing too many activities or the need for reinforcement of the treatment. It 
could also be a real phenomena that requires treatment reinforcement. This provides support for 
Mason et al.'s (1998) call for addressing relapse prevention. 
 
There was also considerable support for Turk et al.'s (1998b) observation that there are multiple 
response patterns to interventions for FM. This would suggest that those potential subjects with 
high pretest psychosocial distress receive psychologic counseling before joining the study. The 
adjustment and symptom management scores improved after the exclusion of these subjects from 
the data analysis. 
 
As with any longitudinal study, attrition was a problem. However, the attrition rate for this 
sample (24%) was less than reports of other studies. Turk et al. (1998A) indicated that they had a 
34% attrition rate at 6 months follow-up and Norregarrd et al. (1997) noted that they had a 40% 
drop-out rate at 12 weeks. Both of these studies were of considerably shorter duration than the 
present study. It is likely that completing five measures over a 1-year period may have been 
difficult for some subjects, or others may have lost interest in participating. 
 
The lack of significant differences in the SEAB scores may have been related to the content of 
the SEAB. It contains the adjustment behaviors that are taught and practiced in the intervention. 
Some control subjects started using these behaviors, giving them a weaker mailed form of the 
intervention, thereby diluting the treatment effect. In fact, some control subjects marked on their 
surveys that they liked receiving their questionnaires because it reminded them of what they 
should be doing to control their FM. 
 
Implications for Future Research/Intervention 
In future studies, the SEAB will be administered only to the treatment group to avoid potential 
contamination of the treatment effect. Alternatively, a three group (group treatment, mailed 
treatment, and attention) longitudinal study design could be used. 
 
The research team will also exclude those potential subjects with high pre-test psychosocial 
distress from the study until after they have received psychotherapy and have improved their 
psychologic status as reported by their therapist. Reinforcement sessions at 6 and 12 months are 
also planned to improve the maintenance of behavioral change. Further research needs to be 
done to refine and test this intervention before it can be used with confidence for FM patients. 
 
Implications for Practice 
FM is a chronic illness that is difficult to diagnose and is characterized by multiple symptoms. It 
takes time and patience to work with FM patients, and there are no quick fixes. Behavior change 
is necessary in helping them take control of their symptoms. 
 
The article can provide direction in the development of comprehensive nursing interventions for 
patients with FM and potentially other musculoskeletal chronic illnesses. It provides a 
framework for behavioral, educational interaction designed to achieve behavioral change to 
control FM symptoms. 
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